Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- CureVac BV (NASDAQ:CVAC) has canceled contract manufacturing deals for its experimental COVID-19 vaccine with two prospective partners.
- The Company would terminate agreements with Celonic Group and Wacker, but existing production deals with Rentschler Biopharma and Novartis AG (NYSE:NVS) would remain unchanged.
- "The continuous increase in mRNA manufacturing capacity together with the progress of large-scale vaccination efforts have strongly changed the demand for our first-generation COVID-19 vaccine, CVnCoV, over the last months," said CureVac Chief Operating Officer Malte Greune.
- CureVac in June and July published disappointing trial data on its initial vaccine candidate, and European regulatory approval is yet outstanding.
- Related: Final Results Confirm CureVac's COVID-19 Vaccine Trails Rivals.
- Read Next: Boehringer Ingelheim Scraps Lung Cancer Program With CureVac.
- It is also working with GlaxoSmithKline Plc (NYSE:GSK) on the next generation of COVID-19 vaccines.
- Related Link: CureVac-GSK's Second-Gen COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action Against Variants.
- Price Action: CVAC shares are down 8.12% at $60.69 during the market session on the last check Tuesday.
- Image by torstensimon from Pixabay
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!